 |
 |

Carcinoma of the GallbladderDoes Radical Resection Improve Outcome?
John H. Donohue, MD;
David M. Nagorney, MD;
Clive S. Grant, MD;
Kenichi Tsushima, MD;
Duane M. Ilstrup, MS;
Martin A. Adson, MD
Arch Surg. 1990;125(2):237-241.
Abstract
 |  |
The records of 111 patients with gallbladder carcinoma operatively treated between 1972 and 1984 were retrospectively reviewed. Fifty-seven percent of patients had distant metastases; another 16% had nodal metastases without distant disease. Median survival was 0.5 years, and 5-year survival was 13%. Clinical jaundice, tumor stage, and tumor grade were all predictive of patient outcome. DNA ploidy, measured in 70 patients, was not a prognostic indicator. In 36% of patients, cholecystectomy (20%) or radical cholecystectomy (16%), which included adjacent liver and regional lymph node resection, was potentially curative. Median survival for patients undergoing radical procedures was 3.6 years, and survival was 0.8 years for patients following cholecystectomy. The 5-year survival rates were comparable (33% vs 32%). While radical cholecystectomy may benefit individual patients and can be accomplished with low morbidity, there was no overall survival advantage compared with cholecystectomy.
(Arch Surg. 1990;125:237-241)
Author Affiliations
From the Departments of Surgery (Drs Donohue, Nagorney, Grant, Tsushima, and Adson) and Biostatistics (Mr Ilstrup), Mayo Clinic, Rochester, Minn.
Footnotes
Accepted for publication September 14, 1989.
Read before the annual meeting of the Society of Surgical Oncology, San Francisco, Calif, May 24, 1989.
Reprint requests to Mayo Clinic, 200 First St SW, Rochester, MN 55905 (Dr Nagorney).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Analysis of Enhancement Pattern of Flat Gallbladder Wall Thickening on MDCT to Differentiate Gallbladder Cancer from Cholecystitis
Kim et al.
Am. J. Roentgenol. 2008;191:765-771.
ABSTRACT
| FULL TEXT
Expression of UDP-N-Acetyl-{alpha}-D-Galactosamine-Polypeptide N-Acetylgalactosaminyltransferase Isozyme 3 in the Subserosal Layer Correlates with Postsurgical Survival of Pathological Tumor Stage 2 Carcinoma of the Gallbladder
Miyahara et al.
Clin. Cancer Res. 2004;10:2090-2099.
ABSTRACT
| FULL TEXT
Thymidine Phosphorylase Expression in Gallbladder Adenocarcinomas
Giatromanolaki et al.
INT J SURG PATHOL 2002;10:181-188.
ABSTRACT
Expressions of Cyclooxygenase-2 and Prostaglandin E-Receptors in Carcinoma of the Gallbladder: Crucial Role of Arachidonate Metabolism in Tumor Growth and Progression
Asano et al.
Clin. Cancer Res. 2002;8:1157-1167.
ABSTRACT
| FULL TEXT
Expression of MUC1 Mucins in the Subserosal Layer Correlates with Postsurgical Prognosis of Pathological Tumor Stage 2 Carcinoma of the Gallbladder
Kawamoto et al.
Clin. Cancer Res. 2001;7:1333-1342.
ABSTRACT
| FULL TEXT
Gallbladder Carcinoma: Radiologic-Pathologic Correlation
Levy et al.
RadioGraphics 2001;21:295-314.
ABSTRACT
| FULL TEXT
The role of cyclooxygenase enzymes in the growth of human gall bladder cancer cells
Grossman et al.
Carcinogenesis 2000;21:1403-1409.
ABSTRACT
| FULL TEXT
Biliary Tract Cancers
de Groen et al.
NEJM 1999;341:1368-1378.
FULL TEXT
The Management of Gallbladder Cancer: Before, During, and After Laparoscopic Cholecystectomy
Pearlstone et al.
SURG INNOV 1998;5:121-128.
ABSTRACT
Hepatopancreatoduodenectomy for Advanced Gallbladder Carcinoma
Nakamura et al.
Arch Surg 1994;129:625-629.
ABSTRACT
Gallbladder Cancer Discovered During Laparoscopic Surgery: Potential for latrogenic Tumor Dissemination
Donohue and Nagorney
Arch Surg 1994;129:561-561.
ABSTRACT
|